SentreHeart gets CE mark; FDA gives StimGuard nod on pivotal trial;

@FierceMedDev: ICYMI: GE Ventures reaffirms commitment to VC with med tech startup program. Article | Follow @FierceMedDev

@VarunSaxena2: #AdvaMed15: CMS has 30 people to evaluate 30,000 diagnostic tests, but more FDA oversight is likely. More | Follow @VarunSaxena2

@EmilyWFierce: CalTech team creates one-time contraceptive vaccine for feral animals. More from FierceAnimalHealth | Follow @EmilyWFierce

> SentreHeart got a CE mark for its Lariat Surgical Left Atrial Appendage Suture Delivery Device. More

> Paris-based Laurane Medical has started a prelaunch of its OmniBone Biopsy System, which can use either a direct or wire-guided approach. More

> FDA gives go ahead to StimGuard for a pivotal trial of what is slated to be the first percutaneously implantable device to treat urgent urinary incontinence from a refractory overactive bladder syndrome. More

Biotech News

@FierceBiotech: Roche looks to shake up the MS market with some promising Phase III data. Report | Follow @FierceBiotech

@JohnCFierce: Westphal's Verastem slashes staff in the wake of a clinical trial flop. News | Follow @JohnCFierce

> Lilly upgrades its NYC research hub, adding 50 jobs in an immuno-oncology push. Story

> Roche picks up a new autoimmune drug with $580M Adheron deal. Report

Pharma News

@FiercePharma: A U.S. nonprofit says it has a better way to make generic drugs. FiercePharmaAsia story | Follow @FiercePharma

@EricPFierce: Sanofi's Kansas City, MO plant back on the block as its August 2016 closing looms. FiercePharmaManufacturing report | Follow @EricPFierce

@CarlyHFierce: Found this today on the futile hunt for things to write about. Five songs about #pharma. More #Friday | Follow @CarlyHFierce

> Pfizer turns aside yet another case alleging Zoloft caused birth defects. Article

> Backlash rages on over Purdue's pediatric OxyContin approval. More